NCT03765229 2024-01-10An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV MelanomaUNC Lineberger Comprehensive Cancer CenterPhase 2 Completed11 enrolled 12 charts
NCT00185302 2015-12-14Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic MelanomaBayerPhase 2 Completed28 enrolled